SCHEMBL1265795

SCHEMBL1265795

CCCCCCCCCCCCCC=CCO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.58
TRPV1 Q8NER1 1/20 0.58
TERT O14746 3/20 0.56
PTPN1 P18031 3/20 0.56
PPARG P37231 3/20 0.56
PPARD Q03181 3/20 0.56
PPARA Q07869 3/20 0.56
TOP1 P11387 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
KMT2A Q03164 2/20 0.56
GMNN O75496 1/20 0.56
USP2 O75604 1/20 0.56
LMNA P02545 1/20 0.56
POLB P06746 1/20 0.56
CYP2C9 P11712 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20178791 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL294780 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2971122 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL8912032 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2971125 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL2974048 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL3491409 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1245079 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1265793 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL5519456 1.00 FAAH (0.58) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118755740-A Vanilla DmGA ox3 gene and application thereof 陕西省西安植物园(陕西省植物研究所) 2024-10-11 CN claimed
US-20180360706-A1 Delivery Particles PROCTER & GAMBLE (US) 2018-12-20 US claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
EP-2563508-A2 DELIVERY PARTICLE The Procter & Gamble Company (US) 2013-03-06 EP claimed
US-20110268802-A1 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY 2011-11-03 US claimed
WO-2010079468-A2 DELIVERY PARTICLE THE PROCTER & GAMBLE COMPANY (US) 2010-07-15 WO claimed
EP-4747001-A2 SILICA CAPSULES The Procter & Gamble Company (US) 2026-05-27 EP disclosed
US-12478942-B2 Methods of making capsules THE PROCTER & GAMBLE COMPANY (US) 2025-11-25 US disclosed
EP-3955890-B1 CAPSULES PROCTER & GAMBLE (US) 2025-07-16 EP disclosed
US-12343696-B2 Capsules THE PROCTER & GAMBLE COMPANY (US) 2025-07-01 US disclosed
US-20250107973-A1 SILICA CAPSULES THE PROCTER & GAMBLE COMPANY 2025-04-03 US disclosed
CN-118755740-B Vanilla DmGA ox3 gene and application thereof 陕西省西安植物园(陕西省植物研究所) 2025-03-18 CN disclosed
US-20250041318-A1 STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF COMMUNITREAT LTD. (IL) 2025-02-06 US disclosed
EP-0545300-A1 Silver halide color photographic material FUJI PHOTO FILM CO., LTD. (JP) 1993-06-09 EP disclosed
EP-0492507-A1 Deinking method and deinking composition KAO CORPORATION (JP) 1992-07-01 EP disclosed
US-5116803-A Optical recording material with resin matrix layer RICOH COMPANY, LTD. (JP) 1992-05-26 US disclosed
US-5068345-A Oxazolidinone aldol adduct EASTMAN KODAK COMPANY (US) 1991-11-26 US disclosed
US-5012000-A Total synthesis of chiral 2-amino-1,3-diols EASTMAN KODAK COMPANY (US) 1991-04-30 US disclosed
US-4977030-A FORMING IMAGE OR ERASING DEPENDENT ON TEMPERATURE RICOH CO., LTD. (JP) 1990-12-11 US disclosed
US-4721819-A Process for the preparation of higher allylic ethers SHELL OIL COMPANY (US) 1988-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250107973-A1 SILICA CAPSULES SRI, MCM4, RCC1 FAAH 4425/4885TRPV1 4490/4885TERT 1216/4885
US-20180360706-A1 Delivery Particles LIPA, CHMP4B, ABCB4 FAAH 661/4885TRPV1 3641/4885TERT 4737/4885
US-20110268802-A1 DELIVERY PARTICLE LIPA, CHMP4B, SLC46A1 FAAH 520/4885TRPV1 3426/4885TERT 4787/4885
US-20250041318-A1 STERILANTS COMPOSITION, KITS AND METHODS OF USE THEREOF NASP, ACR, ALPG FAAH 3987/4885TRPV1 3958/4885TERT 1851/4885
US-12478942-B2 Methods of making capsules FUT6, FUT5, LIPA FAAH 1438/4885TRPV1 4751/4885TERT 1276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.